FDA warns Curaleaf about inflated claims in CBD product marketing
5 years ago
21
A major medical marijuana company is under fire from the FDA. The agency sent Curaleaf a letter of warning over concerns that the cannabis company is marketing some of its products containing CBD as being effective treatments for cancer, Alzheimer's disease, opioid withdrawal and pain.
Loading comments...
-
1:23
WFTX
1 year agoMarco Patriots headed home after helping people impacted by Idalia
808 -
0:42
KMGH
2 years agoBBB warns about travel scams
55 -
0:43
KMGH
2 years agoBBB warns about counterfeit items
52 -
0:53
KMGH
2 years agoBBB warns about weight loss supplements
15 -
1:14
Reuters
2 years agoWHO warns about Ukraine's 'humanitarian catastrophe'
158 -
0:41
KMGH
2 years agoBBB warns about crypto message on Instagram
31 -
1:58
WFTS
2 years agoFBI warns about popular Facebook scam
83 -
1:00:51
The Tom Renz Show
16 hours ago"DEI Is Racist - Who knew & Redfield Now Worries About COVID Jabs"
2.31K3 -
5:01
BIG NEM
8 hours agoInside the Albanian Mob... As a Serb.
1.44K1 -
1:40:14
TheConnieBryanShow
4 days agoGAIN OF FUNCTION: MRNA, D.A.R.P.A. & THE PFIZER PAPERS
1.48K2